Pricing
Login
Home
Charts
Search
Watchlist
Products

Themis Medicare Ltd

THEMISMED
₹94.87-2.18%20 Nov 2026
Reports
Pharma Formulations

Themis Medicare Ltd

THEMISMED
₹94.87
-2.18%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹874Cr
Close
Close Price
₹94.87
Industry
Industry
Pharma Formulations
PE
Price To Earnings
17.25
PS
Price To Sales
2.54
Revenue
Revenue
₹343Cr
Rev Gr TTM
Revenue Growth TTM
0.67%
PAT Gr TTM
PAT Growth TTM
287.73%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
83981231179472987890778790
Growth YoY
Revenue Growth YoY%
-7.122.127.311.713.7-26.7-20.7-33.4-3.96.7-10.915.1
Expenses
ExpensesCr
748994100857710881807313984
Operating Profit
Operating ProfitCr
8929179-6-10-3104-526
OPM
OPM%
9.89.523.714.69.1-8.1-10.3-4.010.94.9-60.36.2
Other Income
Other IncomeCr
6576-2015611977
Interest Expense
Interest ExpenseCr
322232233332
Depreciation
DepreciationCr
332233333333
PBT
PBTCr
8931182-11-14-3109398
Tax
TaxCr
12741-10000141
PAT
PATCr
7725141-10-14-4109257
Growth YoY
PAT Growth YoY%
-44.6-21.135.726.2-92.9-245.5-157.6-125.31,840.4192.0273.1295.0
NPM
NPM%
8.96.820.112.20.6-13.5-14.6-4.611.211.628.37.9
EPS
EPS₹
0.80.72.71.60.1-1.1-1.5-0.41.11.02.70.8
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
83981231179472987890778790
Growth YoY
Revenue Growth YoY%
-7.122.127.311.713.7-26.7-20.7-33.4-3.96.7-10.915.1
Expenses
ExpensesCr
748994100857710881807313984
Operating Profit
Operating ProfitCr
8929179-6-10-3104-526
OPM
OPM%
9.89.523.714.69.1-8.1-10.3-4.010.94.9-60.36.2
Other Income
Other IncomeCr
6576-2015611977
Interest Expense
Interest ExpenseCr
322232233332
Depreciation
DepreciationCr
332233333333
PBT
PBTCr
8931182-11-14-3109398
Tax
TaxCr
12741-10000141
PAT
PATCr
7725141-10-14-4109257
Growth YoY
PAT Growth YoY%
-44.6-21.135.726.2-92.9-245.5-157.6-125.31,840.4192.0273.1295.0
NPM
NPM%
8.96.820.112.20.6-13.5-14.6-4.611.211.628.37.9
EPS
EPS₹
0.80.72.71.60.1-1.1-1.5-0.41.11.02.70.8

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
232217210184202231395354382406342343
Growth
Revenue Growth%
15.1-6.8-3.3-12.39.714.471.1-10.27.76.2-15.60.7
Expenses
ExpensesCr
194184184181166181299287330356342377
Operating Profit
Operating ProfitCr
38332523649966752490-33
OPM
OPM%
16.415.111.91.217.721.524.219.013.512.10.1-9.7
Other Income
Other IncomeCr
346512131825241123120
Interest Expense
Interest ExpenseCr
1212121213139109101111
Depreciation
DepreciationCr
127788991012101010
PBT
PBTCr
171811-13274195735340266
Tax
TaxCr
220-22622161010116
PAT
PATCr
151611-11253673574430151
Growth
PAT Growth%
179.94.9-29.6-195.8330.344.1104.1-21.9-23.5-31.5-96.2287.7
NPM
NPM%
6.57.45.4-5.912.315.518.516.111.47.40.314.8
EPS
EPS₹
2.31.81.2-1.22.73.97.96.24.73.20.15.5
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
232217210184202231395354382406342343
Growth
Revenue Growth%
15.1-6.8-3.3-12.39.714.471.1-10.27.76.2-15.60.7
Expenses
ExpensesCr
194184184181166181299287330356342377
Operating Profit
Operating ProfitCr
38332523649966752490-33
OPM
OPM%
16.415.111.91.217.721.524.219.013.512.10.1-9.7
Other Income
Other IncomeCr
346512131825241123120
Interest Expense
Interest ExpenseCr
1212121213139109101111
Depreciation
DepreciationCr
127788991012101010
PBT
PBTCr
171811-13274195735340266
Tax
TaxCr
220-22622161010116
PAT
PATCr
151611-11253673574430151
Growth
PAT Growth%
179.94.9-29.6-195.8330.344.1104.1-21.9-23.5-31.5-96.2287.7
NPM
NPM%
6.57.45.4-5.912.315.518.516.111.47.40.314.8
EPS
EPS₹
2.31.81.2-1.22.73.97.96.24.73.20.15.5
Sales CAGR
1 Year-16%
3 Years-1%
5 Years8%
TTM1%
EBITDA CAGR
1 Year-99%
3 Years-82%
5 Years-62%
TTM-
PAT CAGR
1 Year-96%
3 Years-73%
5 Years-50%
TTM-
Avg. ROCE
1 Year3%
3 Years9%
5 Years15%
TTM15%
CFO / EBITDA
1 Year-838%
3 Years53%
5 Years39%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
999999999999
Reserves
ReservesCr
66143160149174209278330368393389416
Current Liabilities
Current LiabilitiesCr
130124125147155128110139155156166149
Non Current Liabilities
Non Current LiabilitiesCr
71121291224313534293338
Total Liabilities
Total LiabilitiesCr
275289305314350371428514566588598612
Current Assets
Current AssetsCr
133124143150180185214265293304305316
Non Current Assets
Non Current AssetsCr
142165162164169186214249273284293297
Total Assets
Total AssetsCr
275289305314350371428514566588598612
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
999999999999
Reserves
ReservesCr
66143160149174209278330368393389416
Current Liabilities
Current LiabilitiesCr
130124125147155128110139155156166149
Non Current Liabilities
Non Current LiabilitiesCr
71121291224313534293338
Total Liabilities
Total LiabilitiesCr
275289305314350371428514566588598612
Current Assets
Current AssetsCr
133124143150180185214265293304305316
Non Current Assets
Non Current AssetsCr
142165162164169186214249273284293297
Total Assets
Total AssetsCr
275289305314350371428514566588598612

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
26-281105734162235-3
Investing Cash Flow
Investing Cash FlowCr
-7-40-4-5-16-16-24-16-12-3
Financing Cash Flow
Financing Cash FlowCr
-135-9-107-26-180-9-264
Net Cash Flow
Net Cash FlowCr
50-1-32161-8-3-3-2
Free Cash Flow
Free Cash FlowCr
18-755-53915-13421-8
CFO To PAT
CFO To PAT%
169.2-9.570.0-101.51.3159.647.228.350.8116.3-285.5
CFO To EBITDA
CFO To EBITDA%
67.5-4.631.4479.30.9115.136.023.942.970.8-830.4
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
26-281105734162235-3
Investing Cash Flow
Investing Cash FlowCr
-7-40-4-5-16-16-24-16-12-3
Financing Cash Flow
Financing Cash FlowCr
-135-9-107-26-180-9-264
Net Cash Flow
Net Cash FlowCr
50-1-32161-8-3-3-2
Free Cash Flow
Free Cash FlowCr
18-755-53915-13421-8
CFO To PAT
CFO To PAT%
169.2-9.570.0-101.51.3159.647.228.350.8116.3-285.5
CFO To EBITDA
CFO To EBITDA%
67.5-4.631.4479.30.9115.136.023.942.970.8-830.4

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3045565112722212588591,0732,0161,350607874
Price To Earnings
Price To Earnings
19.034.845.28.97.211.818.946.345.3548.917.3
Price To Sales
Price To Sales
1.32.62.41.51.11.12.23.05.33.31.82.5
Price To Book
Price To Book
4.14.83.82.21.51.43.43.55.83.61.72.2
EV To EBITDA
EV To EBITDA
10.618.723.1151.38.56.59.517.040.628.91,774.2-27.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.255.455.350.556.656.653.557.955.359.452.852.8
OPM
OPM%
16.415.111.91.217.721.524.219.013.512.10.1-9.7
NPM
NPM%
6.57.45.4-5.912.315.518.516.111.47.40.314.8
ROCE
ROCE%
15.613.59.5-0.314.617.728.319.013.310.22.515.3
ROE
ROE%
20.610.56.7-6.813.516.325.416.811.57.40.311.9
ROA
ROA%
5.55.53.7-3.47.19.617.011.17.75.10.28.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
3045565112722212588591,0732,0161,350607874
Price To Earnings
Price To Earnings
19.034.845.28.97.211.818.946.345.3548.917.3
Price To Sales
Price To Sales
1.32.62.41.51.11.12.23.05.33.31.82.5
Price To Book
Price To Book
4.14.83.82.21.51.43.43.55.83.61.72.2
EV To EBITDA
EV To EBITDA
10.618.723.1151.38.56.59.517.040.628.91,774.2-27.9
Profitability Ratios
Profitability Ratios
GPM
GPM%
51.255.455.350.556.656.653.557.955.359.452.852.8
OPM
OPM%
16.415.111.91.217.721.524.219.013.512.10.1-9.7
NPM
NPM%
6.57.45.4-5.912.315.518.516.111.47.40.314.8
ROCE
ROCE%
15.613.59.5-0.314.617.728.319.013.310.22.515.3
ROE
ROE%
20.610.56.7-6.813.516.325.416.811.57.40.311.9
ROA
ROA%
5.55.53.7-3.47.19.617.011.17.75.10.28.3
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr1,1121,0791,025874793782660
Close PriceClose₹469.95320.15511.9094.87147.80223.81285.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE96.7052.8310.5817.25278.8732.1629.26
Price To SalesPS7.181.641.422.541.923.283.99
RevenueRevenueCr155656722343414239165
Revenue Growth TTMRev Gr TTM%8.7%14.3%14.3%0.7%13.1%13.9%
PAT Growth TTMPAT Gr TTM%31.4%-55.0%21.1%287.7%-68.6%-13.6%
Market CapitalizationMkt CapCr1,1121,0791,025874793782660
Close PriceClose₹469.95320.15511.9094.87147.80223.81285.00
IndustryIndustryPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma FormulationsPharma Formulations
Price To EarningsPE96.7052.8310.5817.25278.8732.1629.26
Price To SalesPS7.181.641.422.541.923.283.99
RevenueRevenueCr155656722343414239165
Revenue Growth TTMRev Gr TTM%8.7%14.3%14.3%0.7%13.1%13.9%
PAT Growth TTMPAT Gr TTM%31.4%-55.0%21.1%287.7%-68.6%-13.6%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Sep 26
ResultPPT
Transcript
Summary
Jun 26
ResultPPT
Transcript
Summary
Mar 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Mar 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Jun 24
ResultPPT
Transcript
Summary
Mar 24
ResultPPT
Transcript
Summary
Dec 23
Result
PPT
Transcript
Summary
Jun 23
ResultPPT
Transcript
Summary
Jun 22
Result
PPT
Transcript
Summary
Mar 22
Result
PPT
Transcript
Summary
Dec 21
Result
PPT
Transcript
Summary
Sep 21
Result
PPT
Transcript
Summary
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Sep 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews